ESS - TBIO - Centro de Investigação em Saúde Translacional e Biotecnologia Médica
Permanent URI for this community
Browse
Browsing ESS - TBIO - Centro de Investigação em Saúde Translacional e Biotecnologia Médica by Author "Almeida Vieira, Mónica Andreia"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Betulinic acid and obesity-related disordersPublication . Azevedo, Lara; Ferraz, Ricardo; Vieira, Mónica; Prudêncio, Cristina; Fernandes, Sílvia; Ferraz, Ricardo; Almeida Vieira, Mónica Andreia; Prudêncio, Cristina; Fernandes, SílviaThe obesity epidemic is not just a health issue, it is increasingly driving a shift in the prevalence of chronic diseases, affecting 890 million adults and straining healthcare systems worldwide. Conditions such as type 2 diabetes mellitus, cardiovascular diseases, non-alcoholic fatty liver disease, and various cancer types are closely tied to this growing crisis. Betulinic acid has anti-inflammatory, antioxidant and anti-cancer properties and modulates key metabolic pathways such as NF-κB and AMPK signaling. This compound improves insulin sensitivity, reduces hepatic steatosis, mitigates the progression of atherosclerosis and fibrosis, and suppresses inflammatory responses, which are important in treating those obesity-related disorders. Additionally, betulinic acid use in cancer treatment has been explored due to its potential in angiogenesis and metastasis inhibition and promotion of apoptosis. This review spotlights the therapeutic potential of the natural compound betulinic acid in processes such as insulin sensitivity, glucose and lipid metabolism, adiposity, inflammation, oxidative stress, intestinal microbiota, and other mechanisms underlying different obesity-related disorders. Overall, besides strong therapeutic potential of betulinic acid, described limitations such as poor aqueous solubility, limited bioavailability, production and extraction have resulted in scarce clinical data making it premature to draw definitive conclusions regarding its application in clinical practice.
- Unraveling the nutraceutical potential of Salicornia ramosissima by-product – impact of gastrointestinal digestion and intestinal permeability on in vitro bioactivityPublication . Pinto, Diana; Santos, Inês; Delerue-Matos, Cristina; Teixeira, Filipa; Sut, Stefania; Dall’Acqua, Stefano; Vieira, Mónica; Rodrigues, Francisca; Almeida Vieira, Mónica AndreiaSalicornia ramosissima by-product (SP) is an underexploited antioxidant-rich by-product. This study explored the phytochemical profile, bioaccessibility, and biological activity of SP before and after extraction (SBE and SAE, respectively) upon gastrointestinal simulated digestion and intestinal permeability. The phenolic and flavonoid concentrations increased during digestion, reaching bioaccessibility rates above 95 % for both SBE and SAE. Promising antioxidant/antiradical properties and neuroprotective effects were attested upon digestion. Regarding the phytochemical profile, 17 compounds were identified, including (di)caffeoylquinic acids, gallocatechin, and triterpenoid saponins. The intestinal absorption of bioactive compounds from SAE and SBE intestinal digests was proven through a Caco-2/HT29-MTX cells co-culture model, with 4-caffeoylquinic acid (34.84 %) and 4,5-dicaffeoylquinic acid (26.73 %) reaching the highest permeation rates after 4 h, respectively, for SAE and SBE. These findings support the harnessing of SP as a promising functional and nutraceutical ingredient rich in pro-healthy compounds with proven bioactivity upon in vitro digestion and intestinal permeation.